Luis F Gonzalez-Cuyar
Overview
Explore the profile of Luis F Gonzalez-Cuyar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
1347
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Hasegawa M, Duncan B, Marshall D, Gonzalez-Cuyar L, Paulsen M, Kobayashi M, et al.
Invest Radiol
. 2020 May;
55(10):636-642.
PMID: 32433314
Objectives: We used laser ablation inductively coupled plasma mass spectrometry to quantify gadolinium in hair samples from autopsy cases with gadolinium-based contrast agent (GBCA) exposure. Hair gadolinium data were correlated...
12.
Chen D, Latimer C, Spencer M, Karna P, Gonzalez-Cuyar L, Davis M, et al.
Mov Disord Clin Pract
. 2020 Jan;
7(1):70-77.
PMID: 31970214
Background: Adenylate cyclase 5 (ADCY5)-related dyskinesia is a childhood-onset movement disorder. Manifestations vary in frequency and severity and may include chorea, tremor, dystonia, facial twitches, myoclonus, axial hypotonia, and limb...
13.
Shin K, Francis A, Hill A, Laohajaratsang M, Cimino P, Latimer C, et al.
Sci Rep
. 2020 Jan;
9(1):20392.
PMID: 31892723
Intraoperative consultations, used to guide tumor resection, can present histopathological findings that are challenging to interpret due to artefacts from tissue cryosectioning and conventional staining. Stimulated Raman histology (SRH), a...
14.
Parada C, Osbun J, Busald T, Karasozen Y, Kaur S, Shi M, et al.
Clin Cancer Res
. 2019 Oct;
26(1):193-205.
PMID: 31615938
Purpose: Most World Health Organization (WHO) grade I meningiomas carry a favorable prognosis. Some become clinically aggressive with recurrence, invasion, and resistance to conventional therapies (grade 1.5; recurrent/progressive WHO grade...
15.
Sharma A, Foutz T, Gonzalez-Cuyar L, Latimer C, Longstreth Jr W, Tirschwell D, et al.
Neurohospitalist
. 2019 Sep;
9(4):215-221.
PMID: 31534611
No abstract available.
16.
Johnston S, Whitmire P, Massey S, Kumthekar P, Porter A, Raghunand N, et al.
Am J Clin Oncol
. 2019 Jul;
42(8):655-661.
PMID: 31343422
Although glioblastoma (GBM) is a fatal primary brain cancer with short median survival of 15 months, a small number of patients survive >5 years after diagnosis; they are known as...
17.
Karasozen Y, Osbun J, Parada C, Busald T, Tatman P, Gonzalez-Cuyar L, et al.
Am J Hum Genet
. 2019 Apr;
104(5):968-976.
PMID: 31031011
The role of somatic genetic variants in the pathogenesis of intracranial-aneurysm formation is unknown. We identified a 23-year-old man with progressive, right-sided intracranial aneurysms, ipsilateral to an impressive cutaneous phenotype....
18.
Braggin J, Bucks S, Course M, Smith C, Sopher B, Osnis L, et al.
Ann Clin Transl Neurol
. 2019 Apr;
6(4):762-777.
PMID: 31020001
Objective: Autosomal-dominant familial Alzheimer disease (AD) is caused by by variants in presenilin 1 (), presenilin 2 (), and amyloid precursor protein (). Previously, we reported a rare frameshift variant...
19.
McGuffin S, Bharadwaj R, Gonzalez-Cuyar L, Schiffer J, Stacey A, Walter R, et al.
Clin Infect Dis
. 2019 Jan;
68(3):525-529.
PMID: 30657904
No abstract available.
20.
Moyes K, Davis A, Hoglund V, Haberthur K, Lieberman N, Kreuser S, et al.
Oncoimmunology
. 2018 Nov;
7(11):e1507668.
PMID: 30377570
Efforts to reduce immunosuppression in the solid tumor microenvironment by blocking the recruitment or polarization of tumor associated macrophages (TAM), or myeloid derived suppressor cells (MDSCs), have gained momentum in...